Another study demonstrated that CCR2 inhibition improves apoptosis by influencing PI3K/AKT and p38MARK signaling pathway in DLBCL (diffuse large B-cell lymphoma) cell lines such as SUDHL-2 and OCI-Ly8 [43]. Here, CCR2 is linked to diffuse large B-cell lymphoma.